Ex Vivo Treatment with a Novel Synthetic Aminoglycoside NB54 in Primary Fibroblasts from Rett Syndrome Patients Suppresses MECP2 Nonsense Mutations

Những quyển sách tương tự

• Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model
  Bằng: Brendel, Cornelia, et al.
  Được phát hành: (2010)
• Erratum to: Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model
  Bằng: Brendel, Cornelia, et al.
  Được phát hành: (2013)
• Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations
  Bằng: Nudelman, Igor, et al.
  Được phát hành: (2009)
• Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54
  Bằng: Rowe, Steven M., et al.
  Được phát hành: (2011)
• A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation
  Bằng: Goldmann, Tobias, et al.
  Được phát hành: (2012)